• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Immune thrombocytopenia and thrombosis mortality predictors following SARS-CoV-2 vaccine

byBoaz WongandHarsh Shah
November 10, 2021
in Cardiology, Chronic Disease, Hematology, Infectious Disease, Neurology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Low baseline platelet count and intracranial hemorrhage were shown to be prognostic mortality markers due to vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the adenoviral vector SARS-CoV-2 vaccine.

2. Other correlated factors of mortality associated with VITT thrombosis were shown to be increased D-dimer levels and decreased baseline fibrinogen levels.

Evidence Rating Level: 2 (Good)

Study Rundown: Following adenoviral vector SARS-CoV-2 vaccination (ChAdOx1 nCoV-19), vaccine-induced immune thrombocytopenia and thrombosis (VITT) is possible side-effect with fatal outcomes. As such, this study described patient characteristics of the initial cases of definite or probable VITT following vaccination. The analysis found that baseline platelet count and the presence of intracranial hemorrhage were independent predictors of death. Furthermore, the presence of cerebral venous sinus thrombosis, increased baseline D-dimer, and decreased baseline fibrinogen level were all found to have significant odds of death. The study was limited by case-ascertainment bias, given the global attention on the topic of VITT amongst SARS-CoV-2 vaccines. Furthermore, analysis of this study was carried out before the vaccine was made available to younger populations, which potentially skewed the cohort composition towards older patients. Together, this data supports increased surveillance and supportive measures for patients who exhibit a constellation of features suggesting susceptibility to VITT.

Click to read the study in NEJM

Relevant Reading: Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis

In-Depth [prospective cohort]: A prospective cohort of 220 patients suspected of having vaccine-induced thrombocytosis and thrombopenia (VITT) were identified in the United Kingdom. Patients were confirmed to have VITT if they met the following 5 criteria: symptoms arising 5-30 days after the first dose of the ChAdOx1 nCoV-19 vaccine, presence of thrombosis, thrombocytopenia, increased D-dimer levels (< 4000 fibrinogen-equivalent units), and presence of anti-PF4 antibodies. Patients who did not meet these five criteria were assumed to have probable, possible, or unlikely VITT. Patients who met the criteria thrombofor increased D-dimer levels but not one of the remaining four criteria were classified as probable VITT. Of the 220 patients, 170 patients were classified as definite cases of VITT and 50 patients were determined to have probable cases of VITT. The median age of the cohort was 48 years (interquartile range, 38 to 56) and the median time to presentation was 14 days post-vaccination (interquartile range, 10 to 16). There was no sex predominance. The most common site of thrombosis (50%) at presentation was in the cerebral veins, followed by deep veins of the legs and pulmonary arteries. At the time of analysis, 22% of patients died. Odds of death increased for presence of cerebral venous sinus thrombosis (factor, 2.7; 95% confidence interval [CI], 1.4 – 5.2), increased for platelet count (factor, 1.7 for every 50% decrease from baseline; 95% CI, 1.3 – 2.3), increased for D-dimer level (factor, 1.2 for every increase of 10,000 FEU; 95% CI, 1.0 – 1.3), and increased for fibrinogen level (factor, 1.7 for every 50% decrease, 95% CI, 1.1 – 2.5). Multivariate analysis identified baseline platelet count (< 30,000 / mm3) and presence of intracranial hemorrhage as independently associated factors with mortality. Together, this data supports that increased surveillance and supportive measures should be in place for patients exhibiting lower platelet counts, low fibrinogen levels, and higher D-dimer levels following the ChAdOx1 nCoV-19 vaccine.

RELATED REPORTS

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

Age-based products and longer interdose intervals may reduce the risk of cardiac disease following COVID-19 mRNA vaccination

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cerebral venous thrombosisChAdOx1 nCoV-19 vaccineCOVID-19d-dimerfibrinogenimmune thrombocytopeniaintracranial hemorrhage (ICH)vaccine-induced immune thrombotic thrombocytopenia (VITT)
Previous Post

Inhaled and intranasal ciclesonide for the treatment of COVID-19 in adult outpatients

Next Post

#VisualAbstract: Low-dose computed tomography improves the detection of secondary primary lung cancers compared to chest radiographs for head and neck cancer survivors

RelatedReports

Stem cell transplant may be effective in sickle cell disease
Chronic Disease

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

July 4, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Cardiology

Age-based products and longer interdose intervals may reduce the risk of cardiac disease following COVID-19 mRNA vaccination

June 30, 2022
#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients
StudyGraphics

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

June 30, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Chronic Disease

2 Minute Medicine Rewind June 27, 2022

June 27, 2022
Next Post
#VisualAbstract: Internal mammary node irradiation improves survival for patients with centromedially located node-positive breast cancer

#VisualAbstract: Low-dose computed tomography improves the detection of secondary primary lung cancers compared to chest radiographs for head and neck cancer survivors

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

No difference between noncontrast CT vs MRI for mechanical thrombectomy in patients with large vessel occlusion stroke

Tonsillectomy may have short-term benefits in recurrent throat infection

Amoxicillin shows no benefit in children with uncomplicated lower respiratory tract infections

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early exposure to allergenic foods may reduce incidence of long-term food allergy
  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.